High-dose therapy for primary and metastatic breast cancer

Gary Spitzer, Kenneth Meehan, Douglas Adkins

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

I. INTRODUCTION The utilization of high-dose chemotherapy to treat early and late metastatic and high-risk early-stage breast cancer will be discussed in this chapter. There is some enlargement on the new interest in immediate high-dose therapy, repetitive cycles of therapy, sequential high-dose therapy, and the addition of immunotherapy. The significance of marrow contamination in breast cancer, its detection, and approaches to remove tumor cells are described. The patterns and biology of hematopoietic recovery following high-dose chemotherapy and new approaches to modify and shorten the hematopoietic toxicity following high-dose therapy with recombinant growth factors and peripheral blood cells is described in other chapters in this text.

Original languageEnglish
Title of host publicationHematopoietic Stem Cell Transplantation
PublisherCRC Press
Pages517-536
Number of pages20
ISBN (Electronic)9780824741815
ISBN (Print)9780824702731
StatePublished - Jan 1 2000

Fingerprint Dive into the research topics of 'High-dose therapy for primary and metastatic breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Spitzer, G., Meehan, K., & Adkins, D. (2000). High-dose therapy for primary and metastatic breast cancer. In Hematopoietic Stem Cell Transplantation (pp. 517-536). CRC Press.